MDXG - MiMedx falls as FDA reaffirms position on Axiofill
2024-03-27 09:09:56 ET
More on MiMedx Group
- MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript
- MiMedx Group: Restructuring Changes Are Paying Off
- MiMedx announces new senior secured credit facilities, debt refinancing
- MiMedx gets FDA warning letter over Axiofill production
- Seeking Alpha’s Quant Rating on MiMedx Group